Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Alegzis who wrote (9816)	7/22/1998 9:49:00 AM
From: Hope	Respond to of 14328

A quite the big piece of the puzzle, don't you think?

To: Alegzis who wrote (9816)	7/22/1998 10:16:00 AM
From: dowman	Read Replies (2) \| Respond to of 14328

Public companies are just that.. available to answer questions from shareholders and the interested public. As to my first commentary about HIV 2 licenses, call any of the public companies I have mentioned (EPTO,CALY,SALV(not licensed)SANOFI, ABT,JNJ (licensed) as well as TRIBY and ask about the issue. As I pointed out during that discussion, this will be an issue as long as the FDA is concerned about a valid license as opposed to additional testing. Logic would dictate a change in that policy, but as of today it has not changed, but may. As to private sources at government agencies, they will stay just that .. private sources. If posted I no longer have a source. That should not be a surprise. As to endorsements, the CDC would be sure to communicate the results of testing they do on any product they have been asked to review. How those results are communicated would most likely be the responsibility of the company in question, not the CDC. Which brings up a logical question.. If the CDC has completed the testing of the Trinity product why have those results not been released by the company? Despite the rather personal and histrionic responses by some on this board, my information is factual and balanced. No where have I made a comment about the stock, the price of the stock, nor whether one should buy or not. I will leave those comments to the cheerleaders.